StudyFinder

Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Lung Specimens

Recruiting

We propose to study explanted tissue of patients that are scheduled to undergo single or double lung transplant surgery as a late-stage disease therapeutic strategy. The primary endpoint will be to characterize the composition of the bacterial community in the lung. The secondary endpoint will be to describe bacterial gene expression in the lower airways.

I'm interested

All
18 Years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• diagnosis of cystic fibrosis
• eligible for lung transplantation
• exhausted other available therapies without success
• informed consent
Exclusion Criteria:

• there are no exclusion criteria

Cystic Fibrosis

lung, cystic fibrosis, bacteria, positive diagnosis of CF,, Clinics and Surgery Center (CSC)

Dean Krueger - krue0100@umn.edu
Ryan Hunter
N/A
1404M49426
NCT02128711
See this study on ClinicalTrials.gov

Back